Returns–Not enough quarters yet
These returns are for its stock picks as disclosed on Form 13F: last quarter's holdings, valued at this quarter's prices. They miss trades within each quarter, short positions, options, bonds, cash and fees, so they aren't the returns its clients got.
Top holdings
At the end of June 30, 2026. Change is in shares since the quarter before.2
| Stock | Value | Share of portfolio | Change |
|---|---|---|---|
| KRYSKrystal Biotech Inc | $16.7M | 10.9% | −25.6% |
| TGTXTg Therapeutics Inc | $13.8M | 9.0% | |
| ABVXAbivax Sa | $12.9M | 8.4% | +36.8% |
| CVXChevron Corp | $12.4M | 8.1% | |
| Exxon Mobil CorpCUSIP 30231G102 | $10.7M | 7.0% | +12.1% |
| ARWRArrowhead Pharmaceuticals Inc | $9.0M | 5.9% | +33.5% |
| VKTXViking Therapeutics Inc | $8.2M | 5.3% | |
| CELCCelcuity Inc | $6.5M | 4.2% | −32.2% |
| NKTRNektar Therapeutics | $6.2M | 4.1% | +26.0% |
| TSLATesla Inc | $4.5M | 3.0% | New |
| CYTKCytokinetics Inc | $4.0M | 2.6% | −26.4% |
| ASTSAst Spacemobile Inc | $3.9M | 2.5% | New |
| PVLAPalvella Therapeutics Inc | $3.4M | 2.2% | New |
| AMZNAmazon.com Inc | $3.1M | 2.0% | −60.9% |
| NUVBNuvation Bio Inc | $3.0M | 1.9% | +79.3% |
| XENEXenon Pharmaceuticals Inc | $2.9M | 1.9% | +43.3% |
| ETEnergy Transfer L P | $2.5M | 1.7% | |
| BEBloom Energy Corp | $2.3M | 1.5% | +66.7% |
| FCXFreeport-mcmoran Inc | $2.0M | 1.3% | −15.6% |
| Nebius Group NvCUSIP N97284108 | $1.9M | 1.2% | New |
| ALMSAlumis Inc | $1.5M | 0.9% | −70.4% |
| Ambarella IncCUSIP G037AX101 | $1.4M | 0.9% | New |
| CBRSCerebras Systems Inc | $1.2M | 0.8% | New |
| DFTXDefinium Therapeutics Inc | $1.2M | 0.8% | New |
| NOKNokia Corp | $1.1M | 0.7% | New |
Best picks still held
How each current holding has done since the quarter it first appeared in its filings (up to six years back).
| Stock | Held since | Return since | Now worth |
|---|---|---|---|
| BEBloom Energy Corp | December 31, 2025 | +248.4% | $2.3M |
| MBXMbx Biosciences Inc | March 31, 2026 | +84.9% | $442K |
| TGTXTg Therapeutics Inc | December 31, 2025 | +84.3% | $13.8M |
| AAOIApplied Optoelectronics Inc | March 31, 2026 | +75.2% | $889K |
| NKTRNektar Therapeutics | December 31, 2025 | +65.1% | $6.2M |
| KRYSKrystal Biotech Inc | December 31, 2025 | +50.8% | $16.7M |
| GLUEMonte Rosa Therapeutics Inc | March 31, 2026 | +47.1% | $847K |
| CYTKCytokinetics Inc | December 31, 2025 | +34.1% | $4.0M |
| ALMSAlumis Inc | March 31, 2026 | +27.7% | $1.5M |
| ARWRArrowhead Pharmaceuticals Inc | December 31, 2025 | +22.8% | $9.0M |
Sold off last quarter
- STAAStaar Surgical Co was $1.0M
- SSentinelone Inc was $699K
- LITELumentum Hldgs Inc was $632K
- CRCLCircle Internet Group Inc was $572K
- NVDANvidia Corporation was $488K
- REPLReplimune Group Inc was $470K
- OLMAOlema Pharmaceuticals Inc was $373K
- INCYIncyte Corp was $188K
- CAPRCapricor Therapeutics Inc was $152K
- VPGVishay Precision Group Inc was $130K
Quarter by quarter
| Quarter | Its picks | S&P 500 |
|---|---|---|
| June 30, 2026 | +14.8% | +14.8% |
| March 31, 2026 | +5.2% | −4.6% |
| December 31, 2022 | +4.2% | +7.1% |
| September 30, 2022 | −0.7% | −5.3% |
| June 30, 2022 | −23.7% | −16.5% |
| March 31, 2022 | −23.8% | −4.9% |
| December 31, 2021 | −24.3% | +10.7% |
| September 30, 2021 | −1.1% | +0.3% |
Sources
Every number on this page points here. Each one links to the public record.
- 1SEC EDGAR: Act Capital Management, LLC Form 13F filingshttps://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1442273&type=13F-HR&dateb=&owner=include&count=40CIK 1442273
- 2SEC: 13F for the quarter ended June 30, 2026https://www.sec.gov/Archives/edgar/data/1442273/000163658726000064/Filed July 29, 2026 · accession 0001636587-26-000064